公开(公告)号：US09138157B2

公开(公告)日：2015-09-22

申请号：US14056003

申请日：2013-10-17

Applicant: Medtronic, Inc.

Inventor： Amy E. Thompson-Nauman ,  Michael J Ebert ,  Rick D McVenes ,  Nathan A Grenz

IPC: A61N1/37 ,  A61B5/0402

CPC classification number: A61B5/0402 ,  A61B5/14546 ,  A61B5/686 ,  A61N1/0587 ,  A61N1/37247 ,  A61N1/37258 ,  A61N1/37264 ,  G16H40/63

Abstract: A method and medical device for monitoring cardiac function in a patient that includes a plurality of electrodes to deliver cardiac pacing therapy, and a processor configured to determine a pacing threshold in response to initial delivery of the pacing therapy, determine whether there is a change in the pacing threshold during initial delivery of the pacing therapy, adjust a delivery parameter of the pacing therapy in response to determining the change in the pacing threshold during initial delivery of the pacing therapy, determine whether there is an increase in the pacing threshold during delivery of the adjusted pacing therapy, and determine hypokalemia in response to the increase in the pacing threshold during delivery of the adjusted pacing therapy being present.

Abstract translation: 一种用于监测患者心脏功能的方法和医疗装置，所述方法和医疗装置包括多个用于递送心脏起搏疗法的电极，以及配置成响应于起搏治疗的初始递送确定起搏阈值的处理器，确定是否存在改变 在起搏治疗的初始递送期间的起搏阈值，响应于确定起搏治疗的初始递送过程中起搏阈值的变化，调整起搏治疗的递送参数，确定在分娩期间起搏阈值是否增加 调整的起搏治疗，并且响应于调节起搏治疗的递送期间起搏阈值的增加来确定低钾血症。

公开(公告)号：US08948883B2

公开(公告)日：2015-02-03

申请号：US13869509

申请日：2013-04-24

Applicant: Medtronic, Inc.

Inventor： Michael D Eggen ,  Zhongping Yang ,  Rick D McVenes ,  Noelle C Hurtig ,  Raymond W Usher

IPC: A61N1/05

CPC classification number: A61N1/0573 ,  A61N1/059 ,  A61N1/37205

Abstract: A fixation member of an electrode assembly for an implantable medical device includes a tissue engaging portion extending along a circular path, between a piercing distal tip thereof and a fixed end of the member. The circular path extends around a longitudinal axis of the assembly. A helical structure of the assembly, which includes an electrode surface formed thereon and a piercing distal tip, also extends around the longitudinal axis and is located within a perimeter of the circular path. The tissue engaging portion of the fixation member extends from the distal tip thereof in a direction along the circular path that is the same as that in which the helical structure extends from the distal tip thereof. The electrode assembly may include a pair of the fixation members, wherein each tissue engaging portion may extend approximately one half turn along the circular path.

Abstract translation: 用于可植入医疗装置的电极组件的固定构件包括沿圆形路径延伸的组织接合部分，其穿孔远端和构件的固定端之间。 圆形路径围绕组件的纵向轴线延伸。 包括其上形成的电极表面和穿刺的远端的组件的螺旋结构也围绕纵向轴线延伸并且位于圆形路径的周边内。 固定构件的组织接合部分沿着与其螺旋结构从其远端延伸的方向相同的圆形路径的方向从其远端延伸。 电极组件可以包括一对固定构件，其中每个组织接合部分可以沿着圆形路径延伸约一半匝。

公开(公告)号：US09517336B2

公开(公告)日：2016-12-13

申请号：US14611838

申请日：2015-02-02

Applicant: Medtronic, Inc.

Inventor： Michael D Eggen ,  Zhongping Yang ,  Rick D McVenes ,  Noelle C. Hurtig ,  Raymond W Usher

IPC: A61N1/05 ,  A61N1/372

CPC classification number: A61N1/0573 ,  A61N1/059 ,  A61N1/37205

Abstract: A fixation member of an electrode assembly for an implantable medical device includes a tissue engaging portion extending along a circular path, between a piercing distal tip thereof and a fixed end of the member. The circular path extends around a longitudinal axis of the assembly. A helical structure of the assembly, which includes an electrode surface formed thereon and a piercing distal tip, also extends around the longitudinal axis and is located within a perimeter of the circular path. The tissue engaging portion of the fixation member extends from the distal tip thereof in a direction along the circular path that is the same as that in which the helical structure extends from the distal tip thereof. The electrode assembly may include a pair of the fixation members, wherein each tissue engaging portion may extend approximately one half turn along the circular path.

公开(公告)号：US09421382B2

公开(公告)日：2016-08-23

申请号：US14105306

申请日：2013-12-13

Applicant: Medtronic, Inc.

Inventor： Michael J Ebert ,  Amy Thompson-Nauman ,  Nathan A Grenz ,  Rick D McVenes

IPC: A61N1/00 ,  A61N1/37 ,  A61N1/372

CPC classification number: A61N1/3702 ,  A61N1/37247 ,  A61N1/37258 ,  A61N1/37264 ,  G16H20/10 ,  G16H40/63

Abstract: A method and medical device for monitoring patient medication compliance that includes a plurality of electrodes to deliver a pacing therapy and a processor configured to determine a pacing threshold in response to the delivered pacing therapy, determine whether there is a change in the pacing threshold, and determine patient medication compliance in response to the determined changes.

Abstract translation: 一种用于监测患者药物依从性的方法和医疗装置，其包括用于递送起搏疗法的多个电极和被配置为响应于所发送的起搏治疗来确定起搏阈值的处理器，确定起搏阈值是否发生变化，以及 根据确定的变化确定患者的药物依从性。

公开(公告)号：US09131865B2

公开(公告)日：2015-09-15

申请号：US14056053

申请日：2013-10-17

Applicant: Medtronic, Inc.

Inventor： Amy E. Thompson-Nauman ,  Michael J Ebert ,  Rick D McVenes ,  Nathan A Grenz

IPC: A61N1/37 ,  A61B5/0402

CPC classification number: A61B5/0402 ,  A61B5/0452 ,  A61B2562/0204 ,  A61B2562/0219 ,  A61N1/3622 ,  A61N1/3627 ,  A61N1/3702 ,  A61N1/371

Abstract: A method and medical device for monitoring cardiac function in a patient that includes a plurality of electrodes to deliver cardiac pacing therapy, and a processor configured to determine a pacing threshold in response to initial delivery of the pacing therapy, determine whether there is a change in the pacing threshold during initial delivery of the pacing therapy, adjust a delivery parameter of the pacing therapy in response to determining whether there is a change in the pacing threshold during initial delivery of the pacing therapy, determine whether there is a decrease in the pacing threshold during delivery of the adjusted pacing therapy, and determine hyperkalemia in response to the decrease in the pacing threshold during delivery of the adjusted pacing therapy being present.

Abstract translation: 一种用于监测患者心脏功能的方法和医疗装置，所述方法和医疗装置包括多个用于递送心脏起搏疗法的电极，以及配置成响应于起搏治疗的初始递送确定起搏阈值的处理器，确定是否存在改变 在起搏治疗的初始递送期间的起搏阈值，响应于确定起搏治疗的初始递送期间起搏阈值是否发生变化，调整起搏治疗的输送参数，确定起搏阈值是否有降低 在调整的起搏治疗的交付过程中，并且响应于调节起搏治疗的递送期间起搏阈值的降低来确定高钾血症。